ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESMMAKHTNMDGE........*X0009010-RPUB024739396A120260513EP24748511.32024070820260127enenen202363525493 P20230707US2026051320262020260513202620A61P 35/00 20060101AFI20250125BHEP C07K 16/30 20060101ALI20250125BHEP C07K2317/24 20130101 LA20241007BHEP C07K2317/76 20130101 LA20241007BHEP A61P 35/00 20180101 FI20241007BHEP C07K2317/92 20130101 LA20241008BHEP C07K 16/2863 20130101 LI20241011BHEP A61K2239/57 20230501 LA20241104BHEP A61K 47/6849 20170801 LI20241211BHEP A61K 47/68037 20230801 LI20241211BHEP A61K 47/68031 20230801 LI20241211BHEP A61K 40/4201 20250101 LI20250101RHEP A61K 40/4204 20250101 LI20250101RHEP A61K 40/31 20250101 LI20250101RHEP A61K 40/11 20250101 LI20250101RHEP deHUMANISIERTER 40H3-ANTIKÖRPERenHUMANIZED 40H3 ANTIBODYfrANTICORPS 40H3 HUMANISÉThe United States of America, as represented by The Secretary, Department of Health and Human Services1019945075581P/EP6701 Rockledge Drive, Suite 700 MSC 7788Bethesda, MD 20892-7788USFITZGERALD, David J.Bethesda, Maryland 20892USANTIGNANI, AntonellaBethesda, Maryland 20892USSARNOVSKY, RobertBethesda, Maryland 20892USSymbiosis IP Limited101839150Unit 5C Sbarc l Spark Building Maindy RoadCardiff CF24 4HQGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMEMKMTNLNOPLPTRORSSESISKSMTRBAGEKHMAMDTNUS202403709120240708enWO202501489620250116202503